ZBIO

Zenas Biopharma INC

-$416.8M

Net Activity

Institutions Holding

140

Popularity Rank

#3713

Avg Weight

0.58%

Total Value

$1.1B

Ownership Trend

140 institutions currently hold ZBIO, with 102 net buyers and 52 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

52

Net Buying Institutions

102

Key Holders

View all 140 holding institutions

Quarterly Activity

Recent Activity

+$789.7M

Total Buy Value

$188.4M

Total Sell Value

New buy44
Trim18
Add58
Sold out34

102

Net Buyers

52

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ZENAS BIOPHARMA INC (ZBIO)?
Major stakeholders currently include FMR LLC ($177.6M), SR One Capital Management, LP ($98.5M), NEA Management Company, LLC ($78.7M). Based on the latest 13F filings, there are a total of 140 tracked investment funds and institutions maintaining positions in ZBIO.
What is the overall institutional sentiment toward ZBIO recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $416.8M, driven by 102 managers accumulating shares while 52 reduced their exposure.
Which institutions have been selling or reducing their ZBIO positions?
In the latest period, 18 funds trimmed their holdings, and 34 managers completely exited their positions. The aggregate reported sell value was $188.4M.
Are there any notable investors adding ZBIO to their portfolios?
Yes, buying activity remains notable. 44 institutions opened new positions in {ticker}, and 58 existing holders added to their shares. The total reported buy value for the quarter amounted to $789.7M.

Related Stocks